Frost Science is pleased to announce the addition of William Haseltine, PhD, to its Board of Trustees. He brings deep experience and a passion for innovation to this position. “We are happy to welcome Dr. Haseltine to the Board of Trustees and are confident his experience as a medical scientist and innovator will be invaluable to our efforts,” said Dr. Doug Roberts, Frost Science President and CEO.

Dr. Haseltine is a scientist, businessman, author, and philanthropist. He was previously a professor at Harvard Medical School and the Harvard School of Public Health and is well known for his pioneering work on cancer, HIV/AIDS, and genomics. Dr. Haseltine’s extensive research contributions have resulted in more than 200 manuscripts published in peer-reviewed journals. He has also authored over a dozen books, including works on SARS-CoV-2 variants, long COVID, regenerative medicine, CAR-T cancer treatments, and beyond.

In addition to his groundbreaking scientific achievements, Dr. Haseltine is a prolific innovator in the biotechnology sector. He has founded numerous companies addressing critical needs in the development of cutting-edge pharmaceuticals, as well as advancements in new materials and sustainable fuels. His career exemplifies a commitment to advancing science and improving global health outcomes.

Dr. Haseltine’s addition to the Frost Science Board of Trustees underscores the museum’s dedication to leveraging expertise from diverse fields to inspire and educate the next generation. His insights will be instrumental in shaping the museum’s programs and initiatives as we continue to explore the intersection of science, innovation, and education.